Page 48 - Ryan Weispfenning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article More Patients in Canada Are Now Candidates for a Leadless Pacing Option BRAMPTON, ON, Dec. 21, 2020 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) announced today that it has received a Health Canada licence for Micra™ AV, the world's smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical connection between the chambers of the heart (the atria and the ventricle) is impaired. Medtronic's groundbreaking technology is the first and currently the o...

Medtronic Strengthens Leadership in Navigated, Robotic Spine Surgery with FDA Clearance of Midas Rex Drills and Navigated Disc Prep and Interbodies for U.S. with Mazor Robotic Guidance System Medtronic plc announced that the U.S. Food and Drug Administration has cleared the use of navigated interbody and Midas Rex™ high speed drills with the Mazor™ Robotic Guidance System earlier than originally anticipated. The Mazor™ platform now provides surgeons with unprecedented procedural integration by seamlessly combining the power of Midas Rex™ drills with the market leading visibility and n...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Medtronic Announces Cash Dividend For Third Quarter Of Fiscal Year 2021 December 14, 2020 GMT Medtronic plc (PRNewsfoto/Medtronic plc) DUBLIN, Dec. 14, 2020 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Friday, December 11, 2020, approved the fiscal year 2021 third quarter cash dividend of $0.58 per ordinary share. This quarterly declaration is consistent with the dividend announcement made by the company in June 2020. Medtronic is a constituent of the S&P 500 Dividend Aristocr...

Medtronic plc today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System in the OPuS One Clinical Study the largest, prospective study in RFA for bone metastases. The study, which is the most meaningful clinical data release for the OsteoCool™ technology to date, showed patients had significant and swift improvement in pain relief at just three … – Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS On...

Sean Salmon Named EVP & President Cardiovascular Portfolio; Continues as EVP & President Diabetes Operating Unit News provided by Share this article Share this article DUBLIN, Dec. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice President and President, Cardiovascular Portfolio effective January 1. Salmon will also continue to lead the Diabetes Operating Unit and continue to serve on the company's Executive Committee. He succeeds Mike Coyle, who will leave Medtron...